1. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa).
- Author
-
Lecouvet FE, Simon M, Tombal B, Jamart J, Vande Berg BC, and Simoni P
- Subjects
- Aged, Aged, 80 and over, Humans, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Bone Neoplasms diagnosis, Bone Neoplasms secondary, Bone and Bones pathology, Magnetic Resonance Imaging methods, Prostatic Neoplasms diagnosis, Whole Body Imaging methods
- Abstract
Objective: To compare whole-body MRI (WB-MRI) and axial skeleton MRI (AS-MRI) in detecting and measuring bone metastases in patients with prostate cancer (PCa)., Methods: WB-MRI and AS-MRI examinations were performed in 60 patients with PCa at high risk of metastases. Two radiologists separately categorised the AS-MRI and WB-MRI as negative or positive for metastases, and measured focal metastases using the "Response evaluation criteria in solid tumours" (RECIST) criteria transposed to bone. One radiologist reviewed all examinations 2 months later. Inter- and intraobserver agreements in establishing the presence/absence of metastases were calculated. Bland-Altman plots were used to assess measurement agreement between AS-MRI and WB-MRI., Results: Strong to perfect inter- and intraobserver agreements were found between AS-MRI and WB-MRI in defining the presence/absence of bone metastases. There were no patients with isolated "peripheral" metastases at WB-MRI, missed at AS-MRI. There was no difference in lesion count between the two radiologists. AS-MRI and WB-MRI provided statistically equivalent RECIST values for one radiologist and slightly lower values at AS-MRI for the other., Conclusions: In our series of PCa patients, AS-MRI and WB-MRI were equivalent in determining the presence/absence of bone metastases and provided similar evaluation of the metastatic burden.
- Published
- 2010
- Full Text
- View/download PDF